Four-Factor Prothrombin Complex Concentrate Reduces Time to Procedure in Vitamin K Antagonist-Treated Patients Experiencing Gastrointestinal Bleeding: A Post Hoc Analysis of Two Randomized Controlled Trials
Introduction. To investigate the impact of a 4-factor prothrombin complex concentrate (4F-PCC [Beriplex®/Kcentra®]) versus plasma on “time to procedure” in patients with acute/severe gastrointestinal bleeding requiring rapid vitamin K antagonist (VKA) reversal prior to invasive procedure. Methods. A...
Saved in:
| Main Authors: | Majed A. Refaai, Truptesh H. Kothari, Shana Straub, Jacob Falcon, Ravi Sarode, Joshua N. Goldstein, Andres Brainsky, Laurel Omert, Martin L. Lee, Truman J. Milling |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | Emergency Medicine International |
| Online Access: | http://dx.doi.org/10.1155/2017/8024356 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gestational complications of the prothrombin G20210A mutation related to prothrombin activity
by: M. G. Nikolaeva, et al.
Published: (2020-07-01) -
Efficacy and Safety of Prothrombin complex Concentrate in Patients with Massive Intraoperative Bleeding During non-Cardiac Surgery: A Retrospective Cohort Study
by: Bo Tang MD, et al.
Published: (2025-07-01) -
Thirty‐day mortality with andexanet alfa compared with prothrombin complex concentrate therapy for life‐threatening direct oral anticoagulant‐related bleeding
by: Alexander T. Cohen, et al.
Published: (2022-04-01) -
Clinical significance of antibodies to the phosphatidylserine/prothrombin complex
by: T. M. Reshetnyak, et al.
Published: (2022-05-01) -
Prothrombin complex concentrate for reversal of oral anticoagulants in patients with oral anticoagulation-related critical bleeding: a systematic review of randomised clinical trials
by: Christian Ovesen, et al.
Published: (2025-02-01)